FDMT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - 4D Molecular Therapeutics Inc

Watchlist Manager

Watchlist

Price: 10.45 USD 1.06% Market Closed

Market Cap: $533.5m

	4D Molecular Therapeutics Inc NASDAQ:FDMT	US
	Toro Co NYSE:TTC	US
	Marathon Petroleum Corp NYSE:MPC	US
	Ariana Resources PLC LSE:AAU	UK

Profitability Summary

4D Molecular Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-203%

Negative 3Y Average Operating Margin

-188 337%

Operating Margin is Increasing

-5 148% > -203%

Negative Net Margin

-182%

Negative 3Y Average Net Margin

-164 884%

Net Margin is Increasing

-4 970% > -182%

Negative Free Cash Flow Margin

-147%

Negative 3Y Average Free Cash Flow Margin

-144 289%

Free Cash Flow Margin is Increasing

-4 398% > -147%

Negative ROE

-35%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-226%

ROIC is Increasing

-179% > -121%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.